p62/SQSTM1 excess predicts clinically worse prognoses in oral cancer cases.
- Takuma Inui (330849)
- Tokuhiro Chano (3912)
- Mikiko Takikita-Suzuki (462667)
- Masanori Nishikawa (462668)
- Gaku Yamamoto (287387)
- Hidetoshi Okabe (3916)
Publication date
September 2013
DOIAbstract
<p>Forty-nine cases of oral cancer were immunohistochemically evaluated for p62/SQSTM1 and statistically analyzed relative to the clinical outcomes. Kaplan-Meier curve with log-rank tests was performed for disease-specific survival in relation to p62/SQSTM1 level. (Chi-Square value = 4.640, p = 0.0312).</p
Add to ORKG